{
  "id": 5587806,
  "title": "S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline",
  "url": "https://urgent.news/2026/09/04/s-p-global-ratings-upgrades-teva-to-bbb-marking-third-credit-rating",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-04T15:32:26.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/sp-global-ratings-upgrades-teva-to-bbb-marking-third-credit-rating-upgrade-in-recent-months-and-reflecting-strong-execution-and-financial-discipline"
  },
  "original_language": "en",
  "account": null,
  "summary": "TEL AVIV, Israel, Sept. 04, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that S&P Global Ratings (“S&P”) has upgraded Teva’s long-term issuer credit rating to BBB- from BB+, with a Stable outlook. With this upgrade, along with the other recent upgrades from Fitch and Moody’s, Teva now has […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}